Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database

Author： Moul J.W.   Sun L.   Wu H.   McLeod D.G.   Amling C.   Lance R.   Foley J.   Sexton W.   Kusuda L.   Chung A.   Soderdahl D.   Donahue T.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.6, 2003-11, pp. : 447-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era

By Sun L.   Gancarczyk K.   Paquette E.L.   McLeod D.G.   Kane C.   Kusuda L.   Lance R.   Herring J.   Foley J.   Baldwin D.   Bishoff J.T.   Soderdahl D.   Wu H.   Xu L.   Moul J.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 5, 2001-09 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

By Kupelian P.A.   Elshaikh M.   Reddy C.A.   Zippe C.   Klein E.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 308-309

Elsevier

Access to resources Recommend Favorite

Factors influencing primary care physicians’ decision to order prostate-specific antigen (PSA) test for men without prostate cancer

By Hayat Roshanai Afsaneh   Nordin Karin   Berglund Gunilla  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1602-1608

Informa Healthcare

Access to resources Recommend Favorite

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA

By Grossklaus D.J.   Smith J.A.   Shappell S.B.   Coffey C.S.   Chang S.S.   Cookson M.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 5, 2002-09 ,pp. : 195-198

Elsevier

Access to resources Recommend Favorite

Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1138-1142

Spandidos Publications

Access to resources Recommend Favorite